Home/News/Medical Expert Clarifies Bryan Johnson's Autoimmune Gastritis Diagnosis
Fast Company3 min read

Medical Expert Clarifies Bryan Johnson's Autoimmune Gastritis Diagnosis

Medical Expert Clarifies Bryan Johnson's Autoimmune Gastritis Diagnosis

Biohacker Bryan Johnson announced on social media that he was diagnosed with autoimmune gastritis (AIG), a condition where the stomach is attacked by the immune system. Johnson, who was diagnosed with hyperthyroidism in his 20s, took two decades to discover his AIG, receiving the diagnosis in May at 48 years old. The condition was identified due to his low ferritin levels, despite not having anemia, and was confirmed through an endoscopy and three biopsies. Autoimmune gastritis affects an estimated 2% of the general population and currently has no known cure.

Johnson's announcement sparked widespread online discussion, with many critics linking his condition to his extensive anti-aging and longevity practices, including controversial plasma infusions. Some commenters suggested his pursuit of immortality was ironically undermined by his own body. However, Dr. Sheila Rustgi, a gastroenterologist at Columbia University and co-author of a 2021 study on AIG, provided clarification to Fast Company, addressing the misconceptions surrounding Johnson's diagnosis. She noted that the public discourse often overlooks the nuances of the condition.

Dr. Rustgi explained that autoimmune gastritis is not directly caused by lifestyle choices or anti-aging regimens, but rather by an autoimmune response. While hyperthyroidism, which Johnson has, can be associated with AIG, the condition itself is not a consequence of unconventional health practices. The absence of symptoms, as Johnson himself highlighted, does not equate to the presence of good health, underscoring the importance of regular medical check-ups and diagnostic testing, even in the absence of apparent illness. The viral nature of Johnson's post amplified the public's attention to AIG, prompting expert commentary to ensure accurate understanding of the disease.

Original source — read the full reporting at the publisher:

Read on Fast Company

Read next